	税前利润		日
Acadia Pharmaceuticals	USD 3.98M	22.34M	2026-03
Adma Biologics	USD 57.13M	4.47M	2026-03
ALKERMES	USD -61.93M	122.3M	2026-03
Alterity Therapeutics Limited	AUD -4.74M	3.53M	2024-12
AstraZeneca	USD 3.91B	1.28B	2026-03
BioCryst Pharmaceuticals	USD 248.02M	235.89M	2025-12
Bristol-Myers Squibb	USD 1.47B	1.64B	2025-12
Cipla	INR 7.49B	4.2B	2026-03
Clal Biotechnology	ILS 86.82M	17.9M	2022-12
Compugen	USD -7.66M	64.51M	2026-03
CSL	USD 2.61B	1.21B	2025-12
Eli Lilly	USD 8.27B	1.03B	2025-12
Esperion Therapeutics	USD 63.67M	95M	2025-12
GlaxoSmithKline	GBP 2.14B	919M	2026-03
Grifols	EUR 257.85M	190.87M	2024-12
Halozyme Therapeutics	USD 180.33M	281.18M	2026-03
Ionis Pharmaceuticals	USD -93M	135M	2026-03
J&J	USD 7.82B	2.86B	2026-03
Merck	USD 3.42B	3.32B	2025-12
Minerva Neurosciences	USD 22.51M	30.74M	2024-09
Neurocrine Biosciences	USD 246.8M	7.4M	2026-03
Novartis	USD 3.84B	802M	2026-03
Novavax	USD 17.9M	220.94M	2025-12
Pfizer	USD 5.18B	6.82B	2026-03
Roche Holding	CHF 4.79B	3.01B	2025-06
Sanofi	EUR -1.16B	5.5B	2025-12
Takeda	JPY -52.48B	186.34B	2026-03
Vanda Pharmaceuticals	USD -22.92M	16.68M	2024-12